Search results :

Raloxifene

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G03XC01

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Breast pain Breast pain 4.4% - 29.7% x x x x x x
Vasodilation procedure Vasodilation very common x x
Blood pressure increased Blood pressure increased very common x x
Menopausal symptoms Hot flush very common, 5.9% - 28.7% 6.4% - 18.3% x x x x x x x x
Hot flush Hot flush very common, 5.9% - 28.7% 6.4% - 18.3% x x x x x x x x
Influenza Influenza very common, 13.5% - 14.6% 11.4% - 13.5% x x x x x x x x
Arthralgia Arthralgia 10.7% - 15.5% 10.1% - 14% x x x x x
Musculoskeletal discomfort Arthralgia 10.7% - 15.5% 10.1% - 14% x x x x x
Myalgia 7.7% 6.2% x x x x x
Abdominal pain Abdominal pain 6.6% - 18.7% x x x x x x x x
Gastrointestinal pain Abdominal pain 6.6% - 18.7% x x x x x x x x
Infection Infection 6.8% - 15.1% 14.6% x x x x x
Rhinitis Rhinitis 10.2% 10.1% x x x x x
Bronchitis Bronchitis 9.5% 8.6% x x x x x
Headache Headache 9.2% 8.5% x x x x x x x
Sinusitis Sinusitis 7.9% - 10.3% 6.5% - 7.5% x x x x x
Weight increased Weight increased 8.8% 6.8% x x x x x
Nausea Nausea 8.3% - 8.8% 7.8% - 8.6% x x x x x x x
Myalgia Myalgia 7.7% 6.2% x x x x x
Cough Cough increased 6% - 9.3% 5.7% - 9.2% x x x x x
Diarrhoea Diarrhoea 7.2% 6.9% x x x x x
Pharyngitis Pharyngitis 5.3% - 7.6% 5.1% - 7.2% x x x x x
Depression Depression 6.4% 6% x x x x x
Vaginal haemorrhage Vaginal haemorrhage 2.5% - 88.5% 2.4% x x x x x x
Dyspepsia Dyspepsia 5.9% 5.8% x x x x x x x
Muscle spasms Cramps of lower extremities common, 5.9% - 7% 1.9% - 3.7% x x x x x x x x
Muscle spasms x x x x x x
Dermatitis Rash 5.5% 3.8% x x x x x x x
Rash Rash 5.5% 3.8% x x x x x x x
Insomnia Insomnia 5.5% 4.3% x x x x x
Pain Pain common x x
Oedema peripheral Oedema peripheral common, 3.3% - 5.2% 1.9% - 4.4% x x x x x x x x
Tenderness Tenderness common x x x x x x x
Vaginal inflammation Vaginal inflammation 4.3% 3.6% x x x x x
Vaginal infection Vaginal inflammation 4.3% 3.6% x x x x x
Vertigo Vertigo 4.1% 3.7% x x x x x
Vomiting Vomiting 3.4% - 4.8% 3.3% - 4.3% x x x x x x x
Arthritis Arthritis 4% 3.6% x x x x x
Urinary tract infection Urinary tract infection 4% 3.9% x x x x x
Cystitis Cystitis 3.3% - 4.6% 3.1% - 4.5% x x x x x
Bladder pain Cystitis 3.3% - 4.6% 3.1% - 4.5% x x x x x
Cystitis noninfective Cystitis 3.3% - 4.6% 3.1% - 4.5% x x x x x
Tendon disorder Tendon disorder 3.6% 3.1% x x x x x
Body temperature increased Body temperature increased 3.1% - 3.9% 2.6% - 3.8% x x x x x
Gastrointestinal disorder Gastrointestinal disorder 3.3% 2.1% x x x x x x x
Gastrointestinal symptom NOS x x
Vaginal discharge Leukorrhea 3.3% 1.7% x x x x x
Uterine disorder Uterine disorder 3.3% 2.3% x x x x x x
Flatulence Flatulence 1.6% - 6.4% 2.4% x x x x x
Endometrial disorder Endometrial disorder 3.1% 1.9% x x x x x
Chest pain Chest pain 0.5% - 4% 3.6% x x x x x
Hyperhidrosis Sweating 2.5% - 3.1% 1.7% - 2% x x x x x
Gastroenteritis Gastroenteritis 2.6% 2.1% x x x x x
Pneumonia Pneumonia 2.6% 1.5% x x x x x
Urethral disorder Urinary tract disorder 2.5% 2.1% x x x x x
Urinary tract disorder Urinary tract disorder 2.5% 2.1% x x x x x
Neuralgia Neuralgia 2.4% 1.9% x x x x x
Migraine Migraine 2.4% 2.1% x x x x x x x
Dizziness Syncope 2.3% 2.1% x x x x x
Shock Syncope 2.3% 2.1% x x x x x
Syncope Syncope 2.3% 2.1% x x x x x
Loss of consciousness Syncope 2.3% 2.1% x x x x x
Conjunctivitis Conjunctivitis 2.2% 1.7% x x x x x
Laryngitis Laryngitis 2.2% 1.4% x x x x x
Varicose vein Varicose vein 2.2% 1.5% x x x x x
Hypoaesthesia Hypoaesthesia 2.1% 2% x x x x x
Diabetes mellitus Diabetes mellitus 1.2% 0.5% x
Pulmonary embolism Pulmonary embolism uncommon x x x x x x x x
Thrombocytopenia Thrombocytopenia uncommon x x
Deep vein thrombosis Deep vein thrombosis uncommon x x x x x x x x
Embolism Thromboembolic event uncommon x x x x x x x x
Thrombophlebitis superficial Thrombophlebitis superficial uncommon x x x x
Retinal vein thrombosis Retinal vein thrombosis uncommon x x x x x x x
Retinal vein occlusion Retinal vein occlusion postmarketing x x x
Cerebrovascular accident Cerebrovascular accident postmarketing, uncommon x x x x x
Embolism venous Venous thromboembolism postmarketing x x x x
Bladder cancer Bladder cancer x
Breast disorder Breast disorder x x
Neoplasm malignant Neoplasm malignant x x x x x
Cholelithiasis Cholelithiasis x x x x x x x x
Connective tissue disorder Connective tissue disorder x x
Coronary artery disease Coronary heart disease x x
Flushing Flushing x
Cardiac disorder Cardiac disorder x
Nervous system disorder Nervous system disorder x x
Uterine haemorrhage Uterine haemorrhage x x
Angiopathy Angiopathy x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x x
Endometrial cancer Endometrial cancer x x x x x
Ovarian cancer Ovarian cancer x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

RALOXIFENE (RALOXIFENE HYDROCHLORIDE) / EVISTA (60MG)

Side effects:19
Source:Health Canada

raloxifene / raloxifene hydrochloride

Side effects:33
Source:EMA

raloxifene / raloxifene hydrochloride

Side effects:34
Source:EMA

EVISTA (raloxifene hydrochloride) / EVISTA

Side effects:59
Source:medicines.org.au

RALOXIFENE

Side effects:61
Source:FDA Structured Product Label

RALOXIFENE

Side effects:61
Source:FDA Structured Product Label

Raloxifene

Side effects:61
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label